Achieve Life Sciences Announces Results from Evaluation of Cytisinicline (cytisine) versus Chantix® (varenicline) in 5-HT3 Receptor Binding Assay Study

• NASDAQ: $ACHV
• Notified: $11.96
• 07:01 EDT